Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Inducing labor at 39 weeks for low-risk first-time mothers to reduce cesarean rates

Official title: Labor Induction in Low-risk Nulliparous Women at 39 Weeks of Gestation to Reduce Cesarean: A Randomized Trial of Induction Versus Expectant Management in France (FRENCH-ARRIVE)

Run by University Hospital, Bordeaux · NCT04799912 · Data updated 2026-11-12

This study is testing if starting labor at 39 weeks for first-time moms who are low-risk can help reduce the chances of needing a cesarean section.

More Cesarean Section trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment4200 (estimated)
SponsorUniversity Hospital, Bordeaux
Academic / other
Locations1 site (Bordeaux)
StatusRecruiting
StartedApril 12, 2021
Main results expectedJune 2027
Study endsJune 2027
Registry record updatedFebruary 11, 2025
Trial IDNCT04799912 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are low-risk nulliparous women aged 18 and older, with a singleton pregnancy and a gestational age between 37 and 38 weeks.

Probably not a fit

Patients who are not nulliparous, have multiple pregnancies, or plan for cesarean delivery will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of elective labor induction at 39 weeks of gestation in low-risk nulliparous women compared to expectant management. The study aims to confirm findings from a previous trial in the U.S. that suggested labor induction could lower cesarean delivery rates without increasing adverse perinatal outcomes. Participants will be randomized to receive either labor induction or continue with expectant management, with outcomes measured to assess the frequency of cesarean deliveries and maternal complications. The trial is conducted in France and seeks to provide evidence for potential changes in clinical practice regarding labor induction.

Why it matters

Potential benefit: If successful, this study could lead to a reduction in cesarean deliveries among low-risk first-time mothers, improving maternal and neonatal health outcomes.

How similar studies have gone: Previous studies, such as the ARRIVE trial, have shown promising results with similar approaches, indicating a potential for success in this trial as well.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* Nulliparous women (i.e. no previous pregnancy beyond 20 weeks)
* With singleton gestation. Twin gestation reduced to singleton, either spontaneously or therapeutically, is not eligible unless the reduction occurred before 14 weeks project gestational age
* Gestational age at randomization between 37 weeks of gestation 0 day and 38 weeks of gestation 6 days inclusive based on the crown rump length measured at the first trimester ultrasound before 14 weeks of gestation and 0 day, as recommended in France
* Affiliated or beneficiary to a health security system
* Signed informed consent

Exclusion Criteria:

* Project gestational age at date of first ultrasound \> 14 weeks
* Plan for induction of labor prior to 40 weeks 5 days
* Plan for cesarean delivery or contraindication to labor
* Breech presentation
* Multiple pregnancy
* Signs of labor (regular painful contractions with cervical change)
* Fetal demise or known major fetal anomaly
* Heparin or low-molecular weight heparin during the current pregnancy
* Placenta previa, accreta, vasa previa
* Active vaginal bleeding greater than bloody show
* Ruptured membranes
* Cerclage in current pregnancy
* Known oligohydramnios, defined as Amniotic Fluid Index \< 5 or Maximal Vertical Pocket \< 2 cm
* Fetal growth restriction, defined as Estimated Fetal Weight \< 10th percentile according to local curve
* Known HIV positivity because of modified delivery plan
* Major maternal medical illness associated with increased risk for adverse pregnancy outcome (for example, any diabetes mellitus, lupus, any hypertensive disorder, cardiac disease, renal insufficiency)
* Refusal of blood products
* Contraindication to oxytocin
* Participation in another interventional study that influences management of labor or delivery (labor induction, operative vaginal delivery, cesarean section, shoulder dystocia)
* Delivery planned elsewhere at a non-Network site
* History of myomectomy by laparotomy or laparoscopy
* Previous metroplasty for uterine malformation or Asherman syndrome
* Patient under legal protection
* Poor understanding of the French language

Where it's running

  • CHU de Bordeaux
    Bordeaux, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.